The global injection pens/injectable pens/pen injectors market is
expected to reach USD 67.9 billion by 2025, according to a new report by Grand
View Research, Inc., registering a 9.4% CAGR during the forecast period. High
demand for these devices for management of various chronic as well as acute
diseases and increasing awareness in developing regions are key factors
expected to drive the market.
Injectable pens have witnessed significant
success in improving patient convenience during management of chronic disease,
a process that might include administering intermittent injections. These
devices are more convenient and affordable than other delivery systems. Ongoing
studies on the same to assess their applications in management of other
diseases, including but not limited to Hepatitis C and cancer, is expected to
ensure swift market growth through 2025.
For full research report on Injection
Pen Market visit here:
https://www.grandviewresearch.com/industry-analysis/injection-pens-market
Further key
findings from the study suggest:
- Rising incidence of diseases such as diabetes
and arthritis is primarily boosting market growth
- Increase in government healthcare expenditure
and availability of favorable healthcare insurance policies in developed
as well as developing countries is driving the market
- By product, reusable injectable pens are the
largest and fastest growing segment owing to the advantages associated
with them such as cost effectiveness and patient convenience. Commercially
available reusable injectable pens mainly include Novopen, Luxura,
Berlipen, AllStar, NovoRapid, basalgar, Bydureon, Epipen and Genotropin
- By dosage, variable dosage is the fastest
growing segment. Some of the customizable variable pens are UnoPen,
ServoPen and Ypsopen by Ypsomed, Madie by SHL Group, and Evo pen by
Copernicus
- North America dominates the market, followed
by Europe. Technological advancements and increase in incidence of
osteoporosis, arthritis, and anaphylaxis are factors that can be
attributable to its largest market share
- Asia Pacific is expected to be the fastest
growing region over the forecast period. Better accessibility to
healthcare, coupled with constantly increasing healthcare expenditure in
the region, is fueling market growth
- China is one of the most lucrative markets
with tremendous growth opportunities for global as well as local players.
This is owing to favorable factors such as availability of labor and raw
materials at significantly lower prices as compared to other regions
- Key players in the market include Owen Mumford
Ltd.; GlaxoSmithKline plc; Eli Lilly and Company; Mylan N.V.; AstraZeneca;
Novo Nordisk; Sanofi; and Sandoz Inc.
Get free request sample of this report here: https://www.grandviewresearch.com/industry-analysis/injection-pens-market/request/rs1
Grand
View Research has segmented the global injection pens market on the basis of
product, dosage, application, and region:
Injection
Pens Product Outlook (Revenue, USD Billion, 2014 - 2025)
- Disposable
- Reusable
Injection
Pens Dosage Outlook (Revenue, USD Billion, 2014 - 2025)
- Fixed
- Variable
Injection
Pens Application Outlook (Revenue, USD Billion, 2014 - 2025)
- Diabetes
- Insulin
- Non-insulin
- Anaphylaxis
- Osteoporosis
- Growth hormone
deficiency
- Arthritis
- Others
Injection
Pens Regional Outlook (Revenue, USD Billion, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Greece
- Denmark
- Spain
- Norway
- Belgium
- Austria
- Asia Pacific
- Japan
- China
- India
- Thailand
- Australia
- Singapore
- Malaysia
- Sri Lanka
- Bangladesh
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- UAE
- Saudi Arabia
- South Africa
- Qatar
- Kuwait
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment